Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2025年1月2日 - 9:00PM
Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley
Campbell, President and Chief Executive Officer, will present at
the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco,
CA on Monday, January 13, 2025, at 3:00 p.m. PT.
A live audio webcast of the presentation can also be accessed
via the investors section of the Amicus Therapeutics corporate
website at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
diseases. With extraordinary patient focus, Amicus Therapeutics is
committed to advancing and expanding a pipeline of cutting-edge,
first- or best-in-class medicines for rare diseases. For more
information please visit the company’s website at www.amicusrx.com,
and follow on X and LinkedIn.
CONTACT:
Investors:Amicus
TherapeuticsAndrew FaughnanVice President, Investor
Relationsafaughnan@amicusrx.com (609) 662-3809
Media:Amicus TherapeuticsDiana
MooreHead of Global Corporate Affairs and
Communicationsdmoore@amicusrx.com(609) 662-5079
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
過去 株価チャート
から 12 2024 まで 1 2025
Amicus Therapeutics (NASDAQ:FOLD)
過去 株価チャート
から 1 2024 まで 1 2025
